Ftse Mib
34.326,90
0,51%
DAX
18.686,60
1,07%
S&P 500
5.208,42
0,40%
NASDAQ
16.356,04
0,33%
Bitcoin
61.976,41
1,29%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ EXACT Sciences Corporation (EXAS) EXACT Sciences Corporation (EXAS) Notizie

EXAS

EXACT Sciences (EXAS)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:EXAS
DataOraFonteTitoloSimboloCompagnia
08/05/202423:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EXASEXACT Sciences Corporation
08/05/202423:08Edgar (US Regulatory)Form 424B7 - Prospectus [Rule 424(b)(7)]NASDAQ:EXASEXACT Sciences Corporation
08/05/202423:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EXASEXACT Sciences Corporation
08/05/202422:05Business WireExact Sciences Announces First-Quarter 2024 ResultsNASDAQ:EXASEXACT Sciences Corporation
08/05/202414:29IH Market NewsU.S. Futures Slightly Dip Amid Corporate Earnings and Quiet Economic Calendar, Oil Prices FallNASDAQ:EXASEXACT Sciences Corporation
07/05/202414:00Business WireExact Sciences Demonstrates Continued Scientific Advancement in Colorectal Cancer Screening with Multiple Data Presentations at DDW® 2024NASDAQ:EXASEXACT Sciences Corporation
01/05/202412:00Business WireExact Sciences to Participate in May Investor ConferenceNASDAQ:EXASEXACT Sciences Corporation
15/04/202412:00Business WireExact Sciences Names Aaron Bloomer as New Chief Financial OfficerNASDAQ:EXASEXACT Sciences Corporation
11/04/202412:00Business WireExact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior NotesNASDAQ:EXASEXACT Sciences Corporation
08/04/202418:05Business WireExact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024NASDAQ:EXASEXACT Sciences Corporation
08/04/202412:00Business WireExact Sciences Schedules First Quarter 2024 Earnings CallNASDAQ:EXASEXACT Sciences Corporation
04/04/202412:05Business WireExact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform TreatmentNASDAQ:EXASEXACT Sciences Corporation
28/03/202411:00Business WireExact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-CancerNASDAQ:EXASEXACT Sciences Corporation
27/03/202413:05Business WireExact Sciences Named 2024 Gallup Exceptional Workplace Award WinnerNASDAQ:EXASEXACT Sciences Corporation
13/03/202422:03Business WireThe New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C StudyNASDAQ:EXASEXACT Sciences Corporation
07/03/202413:59Business WireExact Sciences and Basketball Great Jamal Mashburn Encourage Americans 45+ to Have a Game Plan Against Colon CancerNASDAQ:EXASEXACT Sciences Corporation
05/03/202402:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
01/03/202421:53Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXASEXACT Sciences Corporation
26/02/202412:00Business WireExact Sciences to Participate in March Investor ConferenceNASDAQ:EXASEXACT Sciences Corporation
21/02/202423:05Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:EXASEXACT Sciences Corporation
21/02/202422:05Business WireExact Sciences Announces Fourth Quarter 2023 ResultsNASDAQ:EXASEXACT Sciences Corporation
01/02/202412:00Business WireExact Sciences Schedules Fourth Quarter 2023 Earnings CallNASDAQ:EXASEXACT Sciences Corporation
07/01/202422:30PR Newswire (US)Exact Sciences Announces Preliminary Fourth Quarter 2023 ResultsNASDAQ:EXASEXACT Sciences Corporation
02/01/202412:00PR Newswire (US)Exact Sciences to participate in J.P. Morgan Healthcare ConferenceNASDAQ:EXASEXACT Sciences Corporation
07/12/202314:05PR Newswire (US)Exact Sciences Awards Grants to 23 Organizations Focused on Increasing Colorectal Cancer ScreeningsNASDAQ:EXASEXACT Sciences Corporation
01/12/202309:00PR Newswire (US)Exact Sciences Presents Multiple Studies at San Antonio Breast Cancer Symposium Supporting Optimization and Individualization of Therapy for Breast Cancer PatientsNASDAQ:EXASEXACT Sciences Corporation
17/11/202313:10PR Newswire (US)Exact Sciences Files Patent Infringement Lawsuit Against GeneoscopyNASDAQ:EXASEXACT Sciences Corporation
01/11/202321:17Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
01/11/202321:05PR Newswire (US)Exact Sciences Announces Third-Quarter 2023 ResultsNASDAQ:EXASEXACT Sciences Corporation
01/11/202311:00PR Newswire (US)Exact Sciences to participate in November investor conferencesNASDAQ:EXASEXACT Sciences Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:EXAS

La tua Cronologia

BIT
BPE
Bper Banca
BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
NEXI
Nexi S.p.A
BIT
BAMI
Banco BPM
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
PRY
Prysmian
BIT
ENI
Eni
BIT
RACE
Ferrari NV
BIT
LDO
Leonardo
BIT
STMMI
ST Microelectronics
BIT
FBK
Finecobank
BIT
TIT
Telecom Italia
BIT
SRG
Snam
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network